←
Cardiac Trials2,357 posts
Cardiac Trials avatar

Cardiac Trials

@CardiacTrials

Simplified landmark cardiology trials app 📱 by Justin Sharim MD. Mission: to spread evidence-based medicine worldwide 🌎

◷ Joined March 2022▧ 1,431 Photos and videos
Cardiac Trials avatar
⟳ Cardiac Trials retweeted
Cardiac Trials@CardiacTrials·21 Nov 2023

Prophylactic use of PPI among patients on dual antiplatelet therapy? Because yes we all have 🫀 , but we also have a GI tract as well. COGENT Trial, NEJM 2010 ♥️

Post attachmentPost attachment
Cardiac Trials avatar
⟳ Cardiac Trials retweeted
Cardiac Trials@CardiacTrials·9 Jan 2024

Why do we give statins to patients with coronary artery disease? Where does this data originate? This landmark historic trial — dubbed the king 👑 of statin trials — was the first to definitively show the profound life-prolonging effects of statins. 4S Trial, Lancet 1994 ♥️

Post attachmentPost attachment
Justin Sharim MD avatar
⟳ Cardiac Trials retweeted
Justin Sharim MD@JSharimMD·Sep 20

Five 🔑 2026 trials we’ve added to the @CardiacTrials app this year: 1. WITHDRAW-AF: withdrawing GDMT post afib rhythm control 2. Ez-PAVE: LDL-C targets 3. SINGLE-AF: anticoag in intermediate chadsvasc 4. TRIC-I-HF: Tricuspid valve TEER 5. CORALreef Lipids: oral PCSK9i

#2026 Withdrawing GDMT in patients with improved EF? Lifelong GDMT is standard, long after EF improvement. This trial however showed no outcomes difference with GDMT withdrawal in prior tachycardia mediated cardiomyopathy — once afib was controlled. WITHDRAW-AF Trial, EHJ 2026 ♥️

Post attachmentPost attachment
Cardiac Trials avatar
Cardiac Trials@CardiacTrials·Sep 20

#2026 Withdrawing GDMT in patients with improved EF? Lifelong GDMT is standard, long after EF improvement. This trial however showed no outcomes difference with GDMT withdrawal in prior tachycardia mediated cardiomyopathy — once afib was controlled. WITHDRAW-AF Trial, EHJ 2026 ♥️

Post attachmentPost attachment
Cardiac Trials avatar
⟳ Cardiac Trials retweeted
Cardiac Trials@CardiacTrials·Sep 10

Catheter ablation in end-stage heart failure? A population not previously studied in this context, having been excluded from prior large trials. This trial showed the importance of sinus rhythm maintenance in this vulnerable population. CASTLE-HTx Trial, NEJM 2023 ♥️

Post attachmentPost attachment
Cardiac Trials avatar
Cardiac Trials@CardiacTrials·Sep 19

#echofirst tip: Aortic stenosis leads to overestimation of mitral regurgitation severity Mitral regurgitation leads to underestimation of aortic stenosis severity

Cardiac Trials avatar
⟳ Cardiac Trials retweeted
Cardiac Trials@CardiacTrials·Sep 6

High intensity statin after ACS? A standard of care prior to hospital discharge REGARDLESS of cholesterol levels, due in large part to this trial. High intensity statins: 1️⃣ Atorvastatin 40 or 80 mg daily 2️⃣ Rosuvastatin 20 or 40 mg daily PROVE-IT TIMI 22 Trial, NEJM 2004 ♥️

Post attachmentPost attachment
Prof Derek Connolly avatar
⟳ Cardiac Trials retweeted
Prof Derek Connolly@DrDerekConnolly·Sep 13

the 4 pillars

HFrEF Quadruple therapy - in☝️post #meded 1️⃣ Beta blockade (COPERNICUS, MERIT-HF, CIBIS II) 2️⃣ Renin-angiotensin inhibition (CONSENSUS, SOLVD, PARADIGM-HF) 3️⃣ Mineralocorticoid receptor antagonism (RALES, EPHESUS, EMPHASIS-HF) 4️⃣ SGLT-2 Inhibition (DAPA-HF, EMPEROR-Reduced)

Post attachment
Cardiac Trials avatar
Cardiac Trials@CardiacTrials·Sep 13

A reminder to attendings, fellows, & residents: Let your med students leave early if you can. Give them time to study, to exercise, to be with family, or to simply rest. They need that. ♥️

Cardiac Trials avatar
⟳ Cardiac Trials retweeted
Cardiac Trials@CardiacTrials·Sep 4

HFrEF Quadruple therapy - in☝️post #meded 1️⃣ Beta blockade (COPERNICUS, MERIT-HF, CIBIS II) 2️⃣ Renin-angiotensin inhibition (CONSENSUS, SOLVD, PARADIGM-HF) 3️⃣ Mineralocorticoid receptor antagonism (RALES, EPHESUS, EMPHASIS-HF) 4️⃣ SGLT-2 Inhibition (DAPA-HF, EMPEROR-Reduced)

Post attachment
Cardiac Trials avatar
⟳ Cardiac Trials retweeted
Cardiac Trials@CardiacTrials·Sep 6

Statins for for primary prevention? A well-established concept today with roots in this historic trial. This trial proved the beneficial effects of statins in those with hyperlipidemia alone, a year after the 4S Trial (1994) did so in CAD. WOSCOPS Trial, NEJM 1995 ♥️

Post attachmentPost attachment
Cardiac Trials avatar
Cardiac Trials@CardiacTrials·Sep 13

Cardiac #pharma tip 🫀📚 Na channel blockers (class IC – flecainide, propafenone): slow phase 0 depolarization —> increase QRS duration K channel blockers (class Ill – amiodarone, dofetilide): slow phase 3 repolarization, prolonging action potential —> increase QT interval

Cardiac Trials avatar
⟳ Cardiac Trials retweeted
Cardiac Trials@CardiacTrials·29 Feb 2024

Ezetimibe for patients with acute coronary syndrome? Ezetimibe – blocks the absorption of cholesterol across small intestinal mucosa – with reduced CV mortality in this trial. IMPROVE-IT Trial, NEJM 2015 ♥️

Post attachmentPost attachment